Clinical Trial Update: A Study of Oral L-citrulline in Sickle Cell Disease [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of oral L-citrulline for sickle cell disease has been withdrawn, halting any further enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• L-citrulline (L-citrulline)

Snippet

Sponsor: University of Mississippi Medical Center | Conditions: Sickle Cell Disease | Phase 1 | Status: WITHDRAWN